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Epidermal and immune dysfunction?
Linkage and association studies have unambiguously identified 
PSORS1, which spans the major histocompatibility complex 
(MHC) class I region, as a psoriasis susceptibility locus, and 
additional studies have implicated HLA-C as the most likely can-
didate gene in this locus. In a genome-wide association study of 
594,224 single-nucleotide polymorphisms (SNPs) in 2,622 psori-
asis patients and 5,667 controls, the Genetic Analysis of Psoriasis 
Consortium, as a component of the Wellcome Trust Case Control 
Consortium 2, identified 16 previously unreported loci that were 
strongly associated with psoriasis and confirmed the associa-
tion with variation at HLA-C. Notably, all but one of these loci 
contained an immune-related gene. The SNP that mapped to 
ERAP1, which encodes an amino peptidase that regulates the 
peptides bound to MHC class I molecules, was associated with 
psoriasis in this study only in individuals carrying the HLA-C risk 
allele. The identified susceptibility loci underscore an integrated 
psoriasis pathogenesis model that combines skin barrier function 
(variants in LCE3B and LCE3C), innate immune pathogen sensing 
(NFKBIA, REL, TYK2, IFIH1, and IL28RA), and adaptive immu-
nity involving CD8 T lymphocytes (ERAP1 and ZAP70) and T 
helper type 17 cell responses (TRAF3IP2, TYK2, and IL23R). (Nat 
Genet 42:985–90, 2010) Selected by J. McGrath
Not-so-tight junctions
Although epidermal barrier defects have been recognized as 
a common feature of inflammatory diseases, including atopic 
dermatitis (AD), only defects in the stratum corneum have been 
described. Thus, De Benedetto and colleagues examined the 
composition and function of the other epidermal barrier compo-
nent, tight junctions (TJs), in AD. Epidermal TJs were found to be 
defective in patients with AD. Claudin-1, a transmembrane pro-
tein involved in TJ resistance and permeability, was reduced in 
AD epidermis. In addition, epidermal samples from AD patients 
exhibited defects in resistance and ion transport, signifying a TJ 
defect. Furthermore, SNP analysis of the claudin-1 gene (CLDN1) 
suggested that this gene may be a novel AD susceptibility gene. 
These results indicate that TJ impairment may contribute to the 
overall barrier dysfunction observed in AD patients and that 
a decrease in claudin-1 expression may underlie this defect. 
(J Allergy Clin Immunol, published online 16 December 2010; 
doi:10.10.16/j.jaci.2010.10.018) Selected by H. Williams
Systems check
Inflammation occurs via a complex multicomponent process 
that involves mobilization of immune cells in response to injury, 
pathogens, or irritants. To elucidate the mechanism of such a reac-
tion, Valeyev and colleagues used psoriasis as a model system 
to develop a quantitative mathematical model that describes 
cell population interactions via examination of dose-dependent 
cytokine production rates of cell populations. Although genetics 
studies have indicated that cytokine pathways are involved in the 
genetic susceptibility to psoriasis, an explanation of how genetic 
variations lead to chronic inflammation is lacking. According to 
the model presented here, even small changes in cytokine pro-
duction rates by a single cell population can significantly affect 
the systems properties as a result of altered feedback mecha-
nisms, possibly leading to immune system–mediated pathology 
and chronic inflammation. This model offers insight not only into 
the process of inflammation but also into the prediction of normal 
and pathological immune system responses. (PLoS Comput Biol 
6:e1001024, 2010) Selected by A. Blauvelt
Primed and ready for inflammation
Genetic linkage studies have identified several psoriasis sus-
ceptibility loci, and the human S100A7/S100A15 subfamily 
proteins—small calcium-binding proteins involved in signaling 
processes that link adaptive and innate immunity—are encoded 
within the PSORS4 region and enhanced in inflammation-prone 
psoriatic skin. To identify a functional relationship between 
S100A7/S100A15 and psoriasis skin inflammation susceptibil-
ity, Wolf and colleagues generated bitransgenic mice that con-
ditionally express the single mouse ortholog mS100a7a15 in 
keratinocytes in order to histologically and molecularly recapit-
ulate psoriatic lesions. This skin-targeted expression primed the 
skin for inflammation via induction of immunotropic cyto kines 
and enhancement of CD3/CD4-positive lymphocytes. The 
model suggests a pathogenetic mechanism that links genetic 
susceptibility and inflammation priming in psoriasis and is reg-
ulated, at least in part, by the S100A7/A15 subfamily. (Sci Transl 
Med 2:61ra90, 2010) Selected by A. Blauvelt
Receptor X identified
The receptor for the species B human adenoviruses Ad3, Ad7, 
Ad11, and Ad14 has not yet been identified. Because these com-
mon pathogenic adenoviruses may be useful gene transfer vectors 
for the treatment of epithelial tumors, Wang and colleagues sought 
to identify this receptor. Using Ad3 virions and recombinant Ad3 
dodecahedral particles as a probe, the researchers identified 
desmoglein 2 (DSG2) as a high-affinity receptor for the AdB-2/3 
serotypes. Furthermore, they found that Ad3 interaction with 
DSG2 triggers epithelial-to-mesenchymal transition (EMT), which 
involves cellular transdifferentiation whereby epithelial cells lose 
intercellular junctions and gain mesenchymal cell properties. This 
EMT also facilitates increased access to CD46, Her2/neu, and 
epidermal growth factor receptor via opening of the inter cellular 
junctions. These findings are promising for future treatment of 
epithelial tumors because the identification of DSG2, which has 
been suggested as a marker for such tumors, offers insight into the 
mechanisms employed by adenovirus to gain access to epithelial 
tissue. (Nat Med 17:96–104, 2011) Selected by M. Amagai
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